The present invention relates to an Inhibitor of DJ-1 (PARK7) for use in the treatment or prevention of one or more of autoimmune disease, allergy, infectious disease or cancer, wherein the cancer is not lung cancer. In addition, the present invention relates to pharmaceutical compositions comprising such ihibitorsand kits comprising the inhibitor.